Malaysia is capable of becoming Asia's fertility and cardiology treatments hub by 2020 due to the high quality of health services available in the country.
As such, Malaysia Health Tourism Council (MHTC) chief executive officer Sherene Azli said, the council was working closely with the Health Ministry and private hospitals to achieve the aspiration in the next two years, while at the same time, boosting the country's health tourism industry.
“The success rate of the In Vitro Fertilisation (IVF) treatment in Malaysia is high, which is between 55 to 60 percent, and for cardiology treatment, the National Heart Institute (IJN) already has a very good reputation and it is among the best in Asia.
“The level of demands and the country’s capability to provide the services involved prove that Malaysia has a huge potential to be promoted as a fertility and cardiology treatments hub in the region,” she said when appeared as a guest in Bernama News Channel’s 'Ruang Bicara' programme last night.
Sherene said efficient service and multilingual communication were also among the advantages that made Malaysia have a complete health tourism industry package as well.